TEK and plasma cell myeloma: To this end, we immunized BALB/c mice with a recombinant protein encompassing Ig3–Fn3 of human Tie2 (hTie2) twice weekly for 6 weeks and then fused B lymphocytes isolated from the spleens with cultured myeloma cells (SP2/0) (Fig. 1a).